2017-01-11,Allergan Shifts Strategy to Focus on Growth
2017-01-10,Allergan Hints It Is Ready to Make a Splash for More Near-term Growth
2017-01-09,Allergan Continues Down 'Stepping Stone' Path With Two Deals
2016-12-20,Allergan Takes Biggest Step Yet in 'Stepping Stone' Strategy, Signs $2.9 Billion Breast Cancer Deal
2016-10-17,Allergan And Vitae Pharmaceuticals Announce Expiration Of HSR Waiting Period For Allergan's Proposed Acquisition Of Vitae
2016-09-23,VITAE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Vitae Pharmaceuticals, Inc. (VTAE) Over The Proposed Sale Of The Company To Allergan Plc
2016-09-23,Allergan's Vitae Buy Could Spark More Interest in Kadmon
2016-09-21,Stocks Hold Higher as Fed's Yellen Says Economy Picking Up
2016-09-21,Stocks Hold Higher in Wait for Fed, Crude Jumps on Supply Drop
2016-09-21,Stock Futures Rise as Bank of Japan Tackles Deflation
2016-09-15,INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
2016-09-15,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Regarding The Fairness Of The Sale Of Vitae Pharmaceuticals, Inc. To Allergan Plc For $21.00 Per Share
2016-09-15,Vitae Pharmaceuticals (VTAE) Stock Downgraded at BMO Capital
2016-09-15,VTAE Crosses Above Average Analyst Target
2016-09-14,SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information
2016-09-14,Harwood Feffer LLP Announces Investigation Of Vitae Pharmaceuticals, Inc.
2016-09-14,Vitae Pharmaceuticals (VTAE) Stock Downgraded on $639 Million Allergan Deal
2016-09-14,Allergan's Dealmaking Continues With Vitae Takeout
2016-09-14,Stocks Waver as Oil Tumbles but Apple Lifts Nasdaq
2016-09-14,4 Big Stocks to Add to Your Buy List -- Plus 3 to Avoid
2016-09-14,Fear of Being Left Out Is Lifting Indices
2016-09-14,VITAE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
2016-09-14,Allergan Is Doing All the Right Things
2016-09-14,Stocks Add to Gains as Apple Boosts Dow, Crude Fluctuates
2016-09-14,Vitae Pharmaceuticals (VTAE) Stock Soars on $639 Million Allergan Deal
2016-09-14,Stock Futures Edge Higher After a Rocky Three Days
2016-09-14,Allergan To Acquire Vitae Pharmaceuticals Adding Innovative Development Programs For Dermatologic Conditions
2016-09-01,Vitae Pharmaceuticals To Present At Wells Fargo Healthcare Conference
2016-08-11,Vitae Pharmaceuticals To Present At Wedbush PacGrow Healthcare Conference
2016-08-10,Vitae Pharmaceuticals Appoints Scott Applebaum As General Counsel And Corporate Secretary
2016-08-04,Vitae Pharmaceuticals Enters Oversold Territory (VTAE)
2016-08-03,Vitae Pharmaceuticals Reports Second Quarter 2016 Operating And Financial Results
2016-08-01,Vitae Pharmaceuticals To Announce Second Quarter 2016 Financial Results On August 3, 2016
2016-07-27,Vitae Pharmaceuticals Appoints Daniel M. Junius To Board Of Directors
2016-07-06,Commit To Buy Vitae Pharmaceuticals At $10, Earn 31.3% Annualized Using Options
2016-06-17,Vitae Pharmaceuticals (VTAE) Is Weak On High Volume Today
2016-06-14,Vitae Pharmaceuticals To Present At JMP Securities Life Sciences Conference
2016-06-06,Vitae Pharmaceuticals Announces Appointment Of Carole Sable, M.D., As Chief Medical Officer
2016-05-10,Vitae Pharmaceuticals Reports First Quarter 2016 Operating And Financial Results
2016-05-09,Vitae Pharmaceuticals To Present At IMMUNOLOGY 2016
2016-05-03,Vitae Pharmaceuticals To Announce First Quarter 2016 Financial Results On May 10, 2016
2016-04-14,5 Stocks Under $10 Set to Soar
2016-04-12,Vitae Pharma (VTAE) Stock Gets &lsquo;Outperform&rsquo; Rating at BMO Capital
2016-03-30,Vitae Pharmaceuticals Closes Public Offering Of Common Stock
2016-03-24,Vitae Pharmaceuticals Prices Public Offering Of Common Stock
2016-03-23,Vitae Pharmaceuticals Proposes Public Offering Of Common Stock
2016-03-21,Trade-Ideas: Vitae Pharmaceuticals (VTAE) Is Today's "Perilous Reversal" Stock
2016-03-18,Vitae Pharmaceuticals (VTAE) Stock Continues to Gain on Positive Trial Results
2016-03-17,Vitae Pharmaceuticals (VTAE) Stock Skyrockets on Positive Trial Results
2016-03-17,Pre-Market Activity Shows Heavy Volume And Movement For Vitae Pharmaceuticals (VTAE)
2016-03-16,Vitae Pharmaceuticals Achieves Proof-of-Concept With First-in-Class RORyt Inhibitor In Moderate To Severe Psoriasis
2016-03-14,7 Breakout Stocks Spiking on Big Volume
2016-03-04,RSI Alert: Vitae Pharmaceuticals (VTAE) Now Oversold
2016-03-04,Vitae (VTAE) Stock Plunges on Q4 Loss
2016-03-03,Vitae Pharmaceuticals Reports Fourth Quarter And Full Year 2015 Operating And Financial Results
2016-02-25,Vitae Pharmaceuticals To Announce Fourth Quarter And Full Year 2015 Financial Results On March 3, 2016
2015-12-29,Vitae Pharmaceuticals Doses First Patients In Phase 2a Proof-of-Concept Trial Of VTP-38543 In Atopic Dermatitis
2015-12-17,Vitae Pharmaceuticals Reports Top-Line Results From Remaining Monotherapy Arm Of Phase 2 Clinical Trial Of BI187004 In Overweight Type 2 Diabetes Patients
2015-12-14,Vitae Pharmaceuticals Announces Addition To The NASDAQ Biotechnology Index
2015-12-10,Vitae Pharmaceuticals Opens Phase 2a Proof-of-Concept Trial Of VTP-38543 In Atopic Dermatitis Patients
2015-11-24,Vitae Pharmaceuticals To Present At 27th Annual Piper Jaffray Healthcare Conference
2015-11-18,Vitae Pharmaceuticals Announces Positive Top-Line Results From A Phase 1 Multiple Ascending Dose Trial Of VTP-43742
2015-11-12,REMINDER: Vitae Pharmaceuticals To Host Analyst And Investor Briefing
2015-11-10,Vitae Pharmaceuticals To Present At Stifel 2015 Healthcare Conference
2015-11-09,Ratings Changes Today
2015-11-05,Vitae Pharmaceuticals Reports Third Quarter 2015 Operating And Financial Results
2015-11-02,Vitae Pharmaceuticals To Announce Third Quarter 2015 Financial Results On November 5, 2015
2015-10-20,Vitae Pharmaceuticals To Host Analyst And Investor Briefing
2015-09-30,Vitae Pharmaceuticals Appoints Dr. Karen Bernstein To Board Of Directors
2015-09-29,Vitae Pharmaceuticals Initiates Second Part Of A Phase 1 Multiple Ascending Dose Study Of VTP-43742 In Psoriatic Patients
2015-09-22,Vitae Pharmaceuticals To Ring The NASDAQ Stock Market Closing Bell
2015-09-09,Market News: Apple, Netflix, Vitae Pharmaceuticals
2015-09-08,Vitae Pharmaceuticals Announces Positive Top-Line Results From Initial Phase 1 Study Of First-in-Class RORyt Inhibitor VTP-43742 In Autoimmune Disorders
2015-09-01,4 Biotech Stocks Under $10 to Trade for Breakouts
2015-08-10,Vitae Pharmaceuticals Announces Initiation Of A Phase 1 Multiple Ascending Dose Study Of VTP-43742 In Autoimmune Disorders
2015-08-05,Vitae Pharmaceuticals To Present At Wedbush PacGrow Healthcare Conference
2015-08-04,Vitae Pharmaceuticals Reports Second Quarter 2015 Operating And Financial Results
2015-07-29,Vitae Pharmaceuticals Appoints Dr. John M. Leonard To Board Of Directors
2015-07-28,Vitae Pharmaceuticals To Announce Second Quarter 2015 Financial Results On August 4, 2015
2015-07-27,Vitae Pharmaceuticals And Boehringer Ingelheim To End Collaboration And License Agreement For BACE Inhibitors
2015-06-29,Vitae Pharmaceuticals Announces Top-Line Results From Metformin Arm Of Ongoing Phase 2 Clinical Trial Of BI187004/VTP-34072 In Overweight Type 2 Diabetics
2015-06-29,Vitae Pharmaceuticals Announces Initiation Of A Phase 1 Single Ascending Dose Study Of VTP-43742 In Autoimmune Disorders
2015-06-16,Vitae Pharmaceuticals To Present At JMP Securities Life Sciences Conference
2015-05-13,Vitae Pharmaceuticals To Present At UBS Global Healthcare Conference
2015-05-12,Vitae Pharmaceuticals Reports First Quarter 2015 Operating And Financial Results
2015-05-06,Vitae Pharmaceuticals To Present At Upcoming Meetings
2015-05-05,Vitae Pharmaceuticals To Announce First Quarter 2015 Financial Results On May 12, 2015
2015-04-16,Vitae Pharmaceuticals To Present At Keystone Symposia On Mechanisms Of Pro-Inflammatory Diseases
2015-03-31,Vitae Pharmaceuticals Reports Fourth Quarter And Full Year 2014 Operating And Financial Results
2015-03-27,Vitae Pharmaceuticals to Announce Fourth Quarter and Full Year 2014 Financial Results on March 31, 2015
2015-03-02,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Vitae Pharmaceuticals, Inc.
2015-02-27,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Vitae Pharmaceuticals, Inc. - VTAE
2015-02-27,EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against Vitae Pharmaceuticals, Inc. - VTAE
2015-02-27,Vitae Pharmaceuticals To Present At Cowen And Company 35th Annual Health Care Conference
2015-02-26,BACE Inhibitor BI 1181181 Voluntarily Put On Temporary Clinical Hold For Safety Evaluation
2015-01-28,Vitae Pharmaceuticals Announces Exercise Of Underwriters' Option To Purchase Additional Shares And Closing Of Follow-on Public Offering Of Common Stock
2015-01-23,Vitae Pharmaceuticals Announces Pricing Of Follow-on Public Offering Of Common Stock
2015-01-20,Vitae Pharmaceuticals Launches Proposed Follow-on Public Offering Of Common Stock
2015-01-08,The Best And Worst Analyst Recommendations Of 2014
2014-12-23,Vitae Pharmaceuticals Added To Russell 2000(R) And Russell 3000(R) Indexes
2014-12-08,Vitae Pharmaceuticals Among 2014 Best Places To Work In PA
2014-11-12,Vitae Pharmaceuticals Reports Third Quarter 2014 Operating And Financial Results
2014-11-12,Vitae Pharmaceuticals To Present At Stifel 2014 Healthcare Conference
2014-11-05,Vitae Pharmaceuticals To Announce Third Quarter 2014 Financial Results On November 12, 2014
2014-10-27,Market News: Apple Inc, Vitae Pharmaceuticals, Alexza Pharmaceuticals
2014-10-27,Vitae Pharmaceuticals Announces Exercise Of Underwriters' Option To Purchase Additional Shares Of Initial Public Offering
2014-10-23,Positive Top-Line Results Achieved From Two Phase 1 Clinical Trials Of BACE Inhibitor BI1181181/VTP-37948 In Alzheimer's Disease
2014-09-29,Vitae Pharmaceuticals Announces Closing of Initial Public Offering
2014-09-24,Vitae Pharmaceuticals Announces Pricing Of Initial Public Offering
,
,
